Abstract
Introduction
Osteoarthritis (OA) and rheumatoid arthritis (RA) represent the most common forms of arthritis, which are mainly caused by mechanical and inflammatory components, respectively. Determination of synovial inflammation in synovial biopsies via the histopathological Krenn score may be crucial for correct diagnosis and treatment. Specifically, it remains unclear whether synovitis scores differ among multiple biopsy locations within a single joint.
Materials and methods
Eighty synovial samples were taken from four standardized regions of the knee in 20 patients (ten primary OA, ten secondary OA) undergoing total knee arthroplasty (TKA) or total synovectomy. The Krenn synovitis score (grade 0–9) was determined in a blinded manner by two expert pathologists in all biopsies. Next to the inter-rater reliability, we evaluated the agreement of the determined scores among the four biopsy locations within each knee.
Results
The inter-rater reliability between the two pathologists was very high (Cohen’s kappa = 0.712; r = 0.946; ICC = 0.972). The mean synovitis score was significantly higher in knees with secondary than in primary OA (p = 0.026). Importantly, we found clear differences between the scores of the four different biopsy locations within the individual knee joints, with an average deviation of 10.6%. These deviations were comparable in knees with primary and secondary OA (p = 0.64).
Conclusions
While we confirmed the synovitis score as a reliable and reproducible parameter to assess the histopathological synovitis grade in the knee, the considerable variability within the joint indicates that multiple synovial biopsies from different regions should be obtained to enable reliable results of the synovitis score.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
The synovium is the target tissue of many inflammatory rheumatic diseases such as rheumatoid arthritis (RA), which represents the most prevalent form of autoimmune arthritis [1, 2]. The synovial membrane regulates synovial fluid and also plays an important role in the development of osteoarthritis (OA) [3, 4]. Synovitis leads to aseptic inflammation of the joint associated with swelling, pain and cartilage alterations [5] and constitutes an independent risk factor for knee OA [6]. The gold-standard method to assess synovitis is the histopathological analysis of tissue biopsy samples. This analysis not only allows a differentiation between inflammatory and non-inflammatory arthropathies, but also enables a better understanding of the disease pathophysiology and prognosis, as well as determination of treatment efficacy and identification of novel therapeutic targets [7]. Synovial tissue analysis may also enable personalized therapy in patients with RA [8, 9].
The Krenn histopathological synovitis score is a standardized and reproducible evaluation method, which is used in the differential diagnosis of joint diseases (i.e., inflammatory vs. non-inflammatory arthritis) [10]. This score takes into account three components of synovitis (lining layer hyperplasia, activation of resident cells (stroma) and inflammatory infiltrate). Scores range from 0 to 9, with scores of 1–4 indicating low-grade synovitis and scores of 5–9 indicating high-grade synovitis. Low-grade synovitis is usually associated with primary OA, whereas high-grade synovitis is associated with RA, psoriatic arthritis and other forms of arthritis [10]. While computer-assisted validation of the Krenn synovitis score has previously been demonstrated [11], the score has recently been extended with immunohistochemical markers to further improve sensitivity and specificity [12]. Furthermore, the score has been found to successfully differentiate various arthropathies accurately from normal tissue [13]. However, the site-specificity of the Krenn synovitis score within the same joint has not yet been evaluated in further detail.
Specifically, the minimum number of biopsies or regions for an accurate histological diagnosis has not yet been determined. Therefore, the aim of this study was to evaluate whether the synovitis score is dependent on the region of the knee from which the biopsy is obtained. In this regard, we also sought to determine the minimum number of biopsies required and the locations with the lowest and highest deviations.
Methods
Patients
Eighty synovial samples were obtained intraoperatively from 20 patients as part of the standardized surgical procedure. Specifically, four biopsies were taken from ten consecutive patients with advanced stage primary OA and ten consecutive patients with advanced stage secondary OA undergoing total knee arthroplasty (n = 17) or synovectomy (n = 3) (Table 1). The synovial biopsies were collected from four standardized regions of each knee: the synovial region adjacent to the medial joint compartment [1], the suprapatellar region (dorsal quadriceps) [2], the intercondylar region (around the anterior cruciate ligaments, ACL) [3], and the infrapatellar region (Hoffa fat pad) [4] (Fig. 1). Of the ten patients with secondary OA, eight had been diagnosed with RA, while psoriatic arthritis (PsA) and ankylosing spondylitis (AS) were diagnosed in one of ten patients each. The mean age of the patients at the time of surgery was 66.8 ± 9.3 years. All biopsies were taken according to the recommendations of Najm et al. [8].
Histology
Biopsy samples were fixed in 4% buffered formalin (pH 7.0) and embedded in paraffin for histological and immunohistochemical analyses. The Krenn synovitis score of each biopsy sample was determined in a blinded manner by two expert pathologists (JZ, AL) at two different institutions. There were no prior communications or meetings between the two pathologists regarding the use of scoring systems. Routine hematoxylin and eosin (H&E)-stained slides were graded based on three synovial membrane features (synovial lining cell layer, stroma cell density and inflammatory infiltrate) and the severity of the detected changes as described previously [14, 15]. Scores ranged from 0 to 9, with samples divided into those with low-grade (1–4) and high-grade (5–9) synovitis (Fig. 2).
Statistical analysis
Statistical analyses were performed using SPSS 25 software (version 25.0, IBM, Armonk, New York, USA) and GraphPad Prism7 (GraphPad Software, La Jolla, CA). The inter-rater reliability, or the concordance of two or more evaluators, is an indicator of measurement accuracy and is essential to ensure that a measurement can be replicated independent of the particular evaluator [16]. Specifically, the Pearson correlation coefficient, the Cohen’s kappa coefficient and the intraclass correlation (ICC, two-way mixed effects, absolute agreement, multiple measurements) were calculated to determine agreement of synovitis scores between these raters. Based on 95% confident intervals (CIs), ICCs < 0.5, between 0.5 and 0.75, between 0.75 and 0.9 and > 0.90 indicated poor, moderate, good and excellent reliability, respectively [17]. ICCs were also calculated for the synovitis scores of biopsies among the four locations within each knee (medial, suprapatellar, intercondylar, Hoffa). Deviations were calculated to determine the locations that differed most and least. To compare the synovitis scores between primary OA and secondary OA, we used the unpaired two-sided t test. To compare the synovitis scores between the four biopsy locations, paired one-way analysis of variance (ANOVA) with Tukey’s post hoc analysis was performed. P values < 0.05 were considered statistically significant.
Results
Inter-rater reliability
A total of 80 synovial biopsy samples from 20 patients were analyzed in a blinded manner by two experienced, musculoskeletal pathologists (JZ, AL). Their concordance was excellent, with an ICC of 0.972 (95% CI 0.956–0.982, p < 0.001), Cohen’s kappa of 0.712, and a Pearson’s correlation coefficient of 0.946 (p < 0.001), corresponding to a variance of 89.6% (Fig. 3). Due to the high level of agreement, the data obtained from one rater (JZ) were used for further analysis.
Site specificity of the synovitis score
Although no significant differences in the mean synovitis scores could be detected between any of the four biopsy locations (p > 0.05 for all comparisons, one-way ANOVA), the ratings of the 80 biopsy samples showed considerable variability among the four locations analyzed in 20 patients (Table 1). For example, in patient number 1, the Krenn synovitis score was 1 in the intercondylar region and 9 in the Hoffa fat pad, a result confirmed by both pathologists. Overall, we found a mean SD of 1.06 ± 0.91 (10.6%) among the four biopsy locations with a maximum of 2.2 ± 1.96 (Table 1). There were 7/20 (35%) patients, in which the SD was > 1 (≥ 10%). No consistent, specific clinical picture could be observed in these patients with the highest deviations. Furthermore, in 5/20 (25%) patients, part of the samples within the knee joint were scored in the range of high-grade synovitis (≥ 5), while others were scored in the area of low-grade synovitis (< 5).
The ICC calculated for tissue samples from all four regions was 0.579 (95% CI 0.151–0.817, p = 0.008). ICCs were lower when three (0.497; 95% CI 0.269–0.662, p < 0.001) or two (0.396, 95% CI 0.132–0.580, p = 0.003) samples were analyzed (Table 2). A further analysis to determine which localization differs most from the others revealed that the synovitis score of the Hoffa fat body differed most in both negative and positive directions from other tissue samples only in patients with primary OA (Mean deviation 0.6 ± 2.67, range 10). Patients with secondary OA showed a significantly smaller deviation (− 0.1 ± 0.88, range 3).
Finally, although only 3/10 patients with secondary OA showed mean synovitis scores in the range of high-grade synovitis, the score was significantly higher in samples from patients with secondary than primary OA (p = 0.026; Fig. 4a). The standard deviation in the synovitis score among the four locations did not differ significantly in knees with primary and secondary OA (p = 0.64) (Fig. 4b).
Discussion
In the present study, we demonstrated that the Krenn synovitis score varied considerably among different biopsy locations within the knee joint, indicating that the number of synovial biopsies obtained from each knee joint may be crucial. While it was previously shown that the Krenn synovitis score is highly reproducible [18], more detailed parameters of inter-rater reliability within the knee joint have not been reported. We here confirmed that the results of the Krenn synovitis score obtained by two expert pathologists have a very high inter-rater reliability, expressed by high correlation, ICC and Cohen’s kappa coefficients.
In addition to clinical, serological and imaging criteria, the synovitis score can be important in orthopaedic and rheumatic patients to make the correct diagnosis, especially in those with unclear (mono-)articular diseases [10]. As synovitis scores also provide information about inflammatory progression or regression during therapy, reliable scores have a high relevance in clinical practice [2]. In a previous study in patients with varus knee OA, the synovitis score was not associated with the histological OA grade; however, the authors concluded that the reason for the lack of significant associations may have been that they obtained synovial tissue biopsies only from the suprapatellar region [19]. In another study, MRI-based synovitis correlated with the histologic synovitis scores, but synovial tissue samples were obtained from a random location from the knee [20]. To address these limitations, standardization of tissue biopsies likely improves the comparability of assessments and reported results. In other words, given the inter-site variability of synovitis scores as detected in the present study, the individual assessment of four biopsies for each joint could enable more precise statements regarding the associations with, e.g., cartilage degeneration, MRI-based synovitis, and also treatment protocols.
Although most clinical guidelines do not include recommendations on the number of synovial biopsies for both clinical routine and translational research, the necessity of multiple biopsies from one joint to obtain a reliable synovitis score is a matter of ongoing debate. In this regard, a minimum of four synovial biopsies from different joint areas has been recommended in a previous consensus statement [8]. While another previous study reported moderate to strong correlations between the histological synovitis scores assessed in the medial, lateral and superior knee joint compartment, more detailed information on the variability of synovitis scores within these compartments was not provided [21]. Nonetheless, the authors emphasized the need for biopsies from these three knee compartments. For optimal interpretation of synovial tissue analysis results, a previous review article even recommended a minimum of six biopsies per joint [22]; however, this recommendation was only given in the context of research based on the observation to achieve a variance < 10% in the detection of T-cell activation [23], or to allow a determination of relevant differences in gene expression [24] in the synovial membrane. In the present study, evaluation of four biopsy samples from each joint yielded an ICC indicative of moderate reliability, with a decreasing reliability with fewer samples. Our results are compatible with the observation that the expression of cytokines varies within the same joint [25]. Hoffa fat pads showed the highest deviation in scores, a trend that was mainly observed in primary OA. Further studies including varying numbers of synovial biopsies are needed to confirm or contradict our results. Regarding the variability of synovitis within the knee joint, a previous MRI study in patients with OA demonstrated that synovial thickening typically appeared in the intercondylar region, in the Hoffa fat pad, or in the posterior joint margin [26]. Although we did observe considerable variations among the biopsy locations and the Hoffa fat pad did show the greatest deviations, there were no significant differences among biopsy locations. In particular, the synovitis score was not significantly higher in the intercondylar region or the Hoffa fat pad.
Indeed, tissue biopsy remains the gold standard option for determining the synovitis score. The usefulness of the synovitis score has also been demonstrated for other joints than the knee such as the shoulder (including traumatic diseases), where the score was able to distinguish between intra-articular and extra-articular pathologies [27]. Overall, synovial inflammation plays a critical role in the progression of primary and secondary OA and synovitis correlates with symptom severity [28]. Several anti-inflammatory agents that are successfully used for the treatment of OA have antisynovial effects expressed by reductions of synovitis scores [29]. An example for the local connection between joint damage and synovitis is the observation that medial abnormalities of perimeniscal synovium correlate with the severity of medial chondropathy in patients with medial OA [30]. While we confirmed that the synovitis score was significantly higher in patients with secondary OA than in patients with primary OA [31], our results underline that synovitis may occur in a site-specific manner in patients with both primary and secondary OA of the knee joint.
We acknowledge several limitations of the present study. The number of included patients was relatively small, suggesting the need for additional studies in larger numbers of patients and with long-term follow-up. Moreover, we analyzed patients at advanced stage OA, which is why no statements on the change in synovitis score along different OA grades can be made. Moreover, the RA patients suffered from secondary OA and possibly not (anymore) from high-grade synovitis at the time of biopsy, which was mirrored by the relatively low number of patients with high-grade synovitis. High-grade synovitis is defined by a synovitis score of ≥ 5, which was present in only 3/10 patients with secondary OA due to a rheumatic disease (4/10 when taking into account the highest value from each of the four biopsy locations). The primary reason for lower synovitis scores than expected may have been the advanced stage disease in these patients. In this regard, it is commonly accepted that most active rheumatic diseases are charactered by pronounced synovitis associated with bone erosions, which, due to repair mechanisms, can lead to secondary OA [32]. As recently discussed, only very few studies exist that compare inflammation with different severity stages in OA [20]. Compatible with our results, a previous study has compared local cytokine profiles in early stage and advanced stage knee OA and found lower levels of cytokines such as IL-15 in advanced stage OA [33]. The site specify of histopathological synovitis scores may also be different in patients at early stages of primary and secondary OA or other inflammatory joint diseases. Despite the known limitations of the present study, this work could reliably demonstrate the importance of the histopathological analysis of multiple tissue samples taken from one joint as well as the high reliability and clinical relevance of used scoring system if applied by an experienced pathologist.
In summary, the Krenn synovitis score is a reliable histopathological parameter to assess synovial inflammation in clinical practice. We demonstrated a relevant site specificity of the histopathologic changes within the knee joint with the Hoffa fat pad representing the least reliable location. Further studies are required to confirm the results of the present study in larger patient groups with more included joint disorders.
Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219
Schmidt T, Najm A, Mussawy H, Burghardt R, Oehler N, Krenn V, Ruther W, Niemeier A (2019) General synovitis score and immunologic synovitis score reflect clinical disease activity in patients with advanced stage rheumatoid arthritis. Sci Rep 9(1):8448
Wang X, Hunter DJ, Jin X, Ding C (2018) The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials. Osteoarthritis Cartilage 26(2):165–174
Kleine SA, Budsberg SC (2017) Synovial membrane receptors as therapeutic targets: a review of receptor localization, structure, and function. J Orthop Res 35(8):1589–1605
Sellam J, Berenbaum F (2010) The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 6(11):625–635
Felson DT, Niu J, Neogi T, Goggins J, Nevitt MC, Roemer F, Torner J, Lewis CE, Guermazi A, Group MI (2016) Synovitis and the risk of knee osteoarthritis: the MOST Study. Osteoarthritis Cartilage 24(3):458–464
Orr C, Vieira-Sousa E, Boyle DL, Buch MH, Buckley CD, Canete JD, Catrina AI, Choy EHS, Emery P, Fearon U, Filer A, Gerlag D, Humby F, Isaacs JD, Just SA, Lauwerys BR, Le Goff B, Manzo A, McGarry T, McInnes IB, Najm A, Pitzalis C, Pratt A, Smith M, Tak PP, Thurlings R, Fonseca JE, Veale DJ, Tas SW (2017) Synovial tissue research: a state-of-the-art review. Nat Rev Rheumatol 13(8):463–475
Najm A, Le Goff B, Orr C, Thurlings R, Canete JD, Humby F, Alivernini S, Manzo A, Just SA, Romao VC, Krenn V, Muller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, de Meric BL, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ, Group ESS, Group OSTSI (2018) Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups. Arthritis Res Ther 20(1):265
Barton A, Pitzalis C (2017) Stratified medicine in rheumatoid arthritis-the MATURA programme. Rheumatology (Oxford) 56(8):1247–1250
Krenn V, Perino G, Ruther W, Krenn VT, Huber M, Hugle T, Najm A, Muller S, Boettner F, Pessler F, Waldstein W, Kriegsmann J, Casadonte R, Haupl T, Wienert S, Krukemeyer MG, Sesselmann S, Sunitsch S, Tikhilov R, Morawietz L (2017) 15 years of the histopathological synovitis score, further development and review: a diagnostic score for rheumatology and orthopaedics. Pathol Res Pract 213(8):874–881
Morawietz L, Schaeper F, Schroeder JH, Gansukh T, Baasanjav N, Krukemeyer MG, Gehrke T, Krenn V (2008) Computer-assisted validation of the synovitis score. Virchows Arch 452(6):667–673
Najm A, le Goff B, Venet G, Garraud T, Amiaud J, Biha N, Charrier C, Touchais S, Crenn V, Blanchard F, Krenn V (2019) IMSYC immunologic synovitis score: a new score for synovial membrane characterization in inflammatory and non-inflammatory arthritis. Jt Bone Spine 86(1):77–81
Slansky E, Li J, Haupl T, Morawietz L, Krenn V, Pessler F (2010) Quantitative determination of the diagnostic accuracy of the synovitis score and its components. Histopathology 57(3):436–443
Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, Haupl T (2006) Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49(4):358–364
Krenn V, Morawietz L, Konig B, Otto M, Kriegsmann J, Kopenik A, Bohme T, Haupl T (2006) Low-grade-/high-grade-synovitis: synovitis-score as a gold standard? Orthopade 35(8):853–859
Gisev N, Bell JS, Chen TF (2013) Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Adm Pharm 9(3):330–338
Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428
Krenn V, Morawietz L, Burmester GR, Haupl T (2005) Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis. Z Rheumatol 64(5):334–342
Koller U, Waldstein W, Krenn V, Windhager R, Boettner F (2018) Varus knee osteoarthritis: Elevated synovial CD15 counts correlate with inferior biomechanical properties of lateral-compartment cartilage. J Orthop Res 36(3):841–846
de Lange-Brokaar BJ, Ioan-Facsinay A, Yusuf E, Visser AW, Kroon HM, Andersen SN, Herb-van Toorn L, van Osch GJ, Zuurmond AM, Stojanovic-Susulic V, Bloem JL, Nelissen RG, Huizinga TW, Kloppenburg M (2014) Degree of synovitis on MRI by comprehensive whole knee semi-quantitative scoring method correlates with histologic and macroscopic features of synovial tissue inflammation in knee osteoarthritis. Osteoarthritis Cartilage 22(10):1606–1613
Najm A, Orr C, Gallagher L, Biniecka M, Gaigneux E, Le Goff B, Fearon U, Veale DJ (2018) Knee joint synovitis: study of correlations and diagnostic performances of ultrasonography compared with histopathology. RMD Open 4(1):e000616
Smith MD, Baeten D, Ulfgren AK, McInnes IB, Fitzgerald O, Bresnihan B, Tak PP, Veale D, group Ossi (2006) Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go? Ann Rheum Dis 65(1):93–100
Dolhain RJ, Ter Haar NT, De Kuiper R, Nieuwenhuis IG, Zwinderman AH, Breedveld FC, Miltenburg AM (1998) Distribution of T cells and signs of T-cell activation in the rheumatoid joint: implications for semiquantitative comparative histology. Br J Rheumatol 37(3):324–330
Boyle DL, Rosengren S, Bugbee W, Kavanaugh A, Firestein GS (2003) Quantitative biomarker analysis of synovial gene expression by real-time PCR. Arthritis Res Ther 5(6):R352–R360
Ulfgren AK, Grondal L, Lindblad S, Khademi M, Johnell O, Klareskog L, Andersson U (2000) Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment. Ann Rheum Dis 59(6):439–447
Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, An T, Negendank WG (1995) Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Reson Imaging 13(2):177–183
Stahnke K, Morawietz L, Moroder P, Scheibel M (2019) Synovitis as a concomitant disease in shoulder pathologies. Arch Orthop Trauma Surg 139(8):1111–1116
Scanzello CR, Goldring SR (2012) The role of synovitis in osteoarthritis pathogenesis. Bone 51(2):249–257
Wenham CY, Conaghan PG (2010) The role of synovitis in osteoarthritis. Ther Adv Musculoskelet Dis 2(6):349–359
Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M (2005) Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis—results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13(5):361–367
Krenn V, Morawietz L, Haupl T, Neidel J, Petersen I, Konig A (2002) Grading of chronic synovitis–a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract 198(5):317–325
Figueiredo CP, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, Pereira RM, Rech J, Schett G (2016) Quantification and impact of secondary osteoarthritis in patients with anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 68(9):2114–2121
Scanzello CR, Umoh E, Pessler F, Diaz-Torne C, Miles T, Dicarlo E, Potter HG, Mandl L, Marx R, Rodeo S, Goldring SR, Crow MK (2009) Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 17(8):1040–1048
Funding
Open Access funding enabled and organized by Projekt DEAL. This study was not funded by any individual or organization.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study is in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. According to § 12 “Forschungsvorhaben und Sammlungen von Proben Hamburgisches Krankenhausgesetz (HmbKHG)” the anonymized collection of samples in the course of standard surgical procedures (“surgical waste”) is allowed. Additional ethics approval was therefore not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mussawy, H., Zustin, J., Luebke, A.M. et al. The histopathological synovitis score is influenced by biopsy location in patients with knee osteoarthritis. Arch Orthop Trauma Surg 142, 2991–2997 (2022). https://doi.org/10.1007/s00402-021-03889-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-021-03889-x